Discovery Value Fund Iovance Biotherapeutics, Inc. Transaction History

Discovery Value Fund

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $721,142 - $943,687	-35,437 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$16.33 - $33.07 $520,812 - $1.05 Million	31,893 Added 899.92%	35,437 $922,000
Q4 2020 Feb 03, 2021	BUY	$28.04 - $50.26 $99,373 - $178,121	3,544 New	3,544 $164,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Discovery Value Fund, based on Form 13F filings with the SEC.

Stay updated on Discovery Value Fund with notifications on news.